An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica FDA Compliance for Peptide Therapy and BPC 157 Holt Law The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptide Law: A Healthcare Attorney's Guide to the FD&C Act and Unapproved Drugs Holt Law RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals